Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Induction therapy with paclitaxel and bevacizumab followed by switch maintenance therapy with eribulin in Japanese patients with HER2-negative metastatic breast cancer: a multicenter, collaborative, open-label, phase II clinical study for the SBCCSG 35 investigators.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
No Comments.